Skip to main content

Table 2 Clinical parameters of the first proband after GH treatment

From: Molecular genetic analysis and growth hormone response in patients with syndromic short stature

CA (year)

BA (year)

Height (cm)

Weight (kg)

GH (mg/kg/w)

IGF-1 ng/mL

HbA1c (3.6–6.0%)

INS (2.6–11.8 µU/mL)

T3 (nmol/L)

T4 (nmol/L)

FT3 (pmol/L)

FT4 (pmol/L)

TSH (mIU/L)

4–3/12

2.5

85.8 (− 5.05SD)

13.8 (− 1.74SD)

0.2

88.9 (49–283)

4.7

1.8

3.0 (1.4–3.8)

120.3 (76.6–189.0)

7.1 (3.7–8.5)

17.8 (12.3–22.8)

2.91 (0.7–5.97)

4–4/12

 

86.8 (− 4.93SD)

13.0 (− 2.38SD)

0.2

124 (49–283)

5.2

/

3.4 (1.4–3.8)

145.9 (76.6–189.0)

7.9 (3.7–8.5)

21.0 (12.3–22.8)

2.95 (0.7–5.97)

4–6/12

 

87.1 (− 5.07SD)

14.0 (− 1.86SD)

0.2

93.9 (49–283)

4.8

4.0

3.1 (1.4–3.8)

112.1 (76.6–189.0)

8.1 (3.7–8.5)

18.3 (12.3–22.8)

2.72 (0.7–5.97)

4–9/12

3

90.0 (− 4.71SD)

40.5 (− 1.81SD)

0.2

107 (49–283)

5.2

2.7

2.9 (1.4–3.8)

142.2 (76.6–189.0)

6.7 (3.7–8.5)

20.1 (12.3–22.8)

2.30 (0.7–5.97)

5

 

92.4 (− 4.42SD)

16.95 (− 0.67SD)

0.2

245 (50–286)

4.5

2.9

3.4 (1.4–3.8)

123.8 (76.6–189.0)

8.2 (3.7–8.5)

19.2 (12.3–22.8)

4.19 (0.7–5.97)

5–4/12

4

93.4 (− 4.59SD)

16.0 (− 1.44SD)

0.2

291↑ (50–286)

5.3

4.9

3.2↑ (1.3–3.1)

154.9 (66.0–181.0)

8.1 (3.0–9.1)

22.4↑ (12.0–22.0)

1.93 (0.27–4.2)

5–7/12

 

95.3 (− 4.46SD)

17.5 (− 0.93SD)

0.3

149 (50–286)

5.1

2.1

3.3↑ (1.3–3.1)

157.0 (66.0–181.0)

8.3 (3.0–9.1)

23.1↑ (12.0–22.0)

3.21 (0.27–4.2)

5–10/12

4.5

97.5 (− 4.19SD)

18.0 (− 0.88SD)

0.3

473↑ (50–286)

5.3

9.1

3.6 (1.3–3.1)

171.4 (66.0–181.0)

8.3 (3.0–9.1)

27.2↑ (12.0–22.0)

1.46 (0.27–4.2)

6–1/12

 

99.6 (− 3.96SD)

19.0 (− 0.65SD)

0.2

416↑ (52–297)

5.1

5.6

3.7 (1.3–3.1)

148.0 (66.0–181.0)

8.6 (3.0–9.1)

22.1↑ (12.0–22.0)

1.61 (0.27–4.2)

6–4/12

5

100.4 (− 4.02SD)

18.0 (− 1.25SD)

0.2

304 (52–297)

5.1

4.2

3.2↑ (1.3–3.1)

128.7 (66.0–181.0)

7.7 (3.0–9.1)

19.4 (12.0–22.0)

1.87 (0.27–4.2)

  1. T3 triiodothyronine, T4 thyroxine, FT3 free triiodothyronine, FT4 free thyroxine, TSH thyroid-stimulating hormone